Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV).
about
HIV and liver transplantation: The British Columbia experience, 2004 to 2013.Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000.New hopes for HIV and HCV coinfection in 2004.Review article: current status of liver transplantation in HIV-infected patients.Drug interactions in the management of HIV infection.Liver transplantation().A review of nelfinavir for the treatment of HIV infection.The role of cytochrome P450 in antiretroviral drug interactions.Drug interactions in the management of HIV infection: an update.Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years.Drug-induced liver injury: the role of drug metabolism and transport.Drug metabolism and liver disease: a drug-gene-environment interaction.Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: a case report.The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.Symptomatic orthostasis with extended-release nifedipine and protease inhibitors.Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients.Tacrolimus and lopinavir/ritonavir interaction in liver transplantation.Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.Long-Term Outcome of Liver Transplantation in HIV-1-Positive Patients: 15-Year Follow-Up
P2860
Q34238552-A0E6B206-5253-4FBC-9246-14C557E717C7Q34614976-76E5B996-BDA1-4311-9D34-A44300323189Q35912407-3F5F91F0-608D-4096-BDD1-A08921BA75E7Q35966062-4914E2AD-F584-499B-9D67-22BC5F1DE02AQ36066083-13FF507E-B35F-4F5A-9A4B-5D2C4B39F27AQ36340199-BA55DE13-75F4-4E5F-8D29-5C9A37E4FF8FQ36546278-ACCAF216-6D15-4F4F-9C9C-25E9EB4F6274Q36909336-88C041E5-E8E3-4F6E-8BBB-7487BF54AD2AQ37000733-E763C443-74BB-48F3-BE2F-913C9443CDA9Q37837963-72DB0C24-68BF-4030-A459-E8693BC18B8BQ38084215-3D01C4FF-2477-4B50-BEE1-4359DB95CE24Q39037269-9A3D1427-1DC1-492D-ABFD-C8F15E57B2D5Q44117968-6AFF5616-D7FA-4D9A-BF07-A49471B70194Q44117969-1D4C5D6D-05C1-4B04-A5C8-2EAC03E4CCEDQ44186647-125982F8-E80A-42ED-A2A2-07DACA093755Q44439965-14AF8448-91E0-43CA-86AE-7EECC6CE84F7Q44665226-6A5C0E21-DF16-4E48-A010-CE47E0DC52C3Q45514449-63A07D20-8B06-4FDB-A7AB-CFA69441D14DQ57761462-891326F4-0D6F-4F62-A96F-37DDCE198821
P2860
Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV).
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Interaction between nelfinavir ...... V and hepatitis C virus (HCV).
@en
Interaction between nelfinavir ...... with HIV and hepatitis C virus
@nl
type
label
Interaction between nelfinavir ...... V and hepatitis C virus (HCV).
@en
Interaction between nelfinavir ...... with HIV and hepatitis C virus
@nl
prefLabel
Interaction between nelfinavir ...... V and hepatitis C virus (HCV).
@en
Interaction between nelfinavir ...... with HIV and hepatitis C virus
@nl
P2093
P1433
P1476
Interaction between nelfinavir ...... V and hepatitis C virus (HCV).
@en
P2093
P304
P356
10.1097/00007890-200005270-00041
P577
2000-05-01T00:00:00Z